Co-Occurrence of tet(X4) and bla NDM-5 in Escherichia coli Isolates of Inpatient Origin in Guangzhou, China.
Haijun ChenYi ZhanLinjing WangZhirou XiaoDonghua FengZhemei ChenHaitao LiuDingqiang ChenZhenbo XuLing YangPublished in: Microbial drug resistance (Larchmont, N.Y.) (2023)
Tigecycline, one of the last-resort therapeutic options for complicated infections caused by multidrug-resistant pathogens, especially carbapenem-resistant Enterobacterales and Acinetobacter in recent years. The emergence of antibiotic-resistant bacteria and antibiotic-resistant genes has threatened the effectiveness of antibiotics and public health with the excessive use of antibiotics in clinics. However, the emergence and dissemination of high-level mobile tigecycline-resistance gene tet(X) is challenging for clinical effectiveness of antimicrobial agent. This study aimed to characterize an E. coli strain T43, isolated from an inpatient in a teaching hospital in China. The E. coli T43 was resistant to almost all antimicrobials except colistin and consisted of a 4,774,080 bp chromosome and three plasmids. Plasmids pT43-1 and pT43-2 contained tigecycline-resistance gene tet(X4) . Plasmid pT43-1 had a size of 152,423 bp with 51.05% GC content and harbored 151 putative open reading frames. pT43-1 was the largest plasmid in strain T43 and carried numerous resistance genes, especially tigecycline resistance gene tet(X4) and carbapenemase resistance gene bla NDM-5 . The tet(X) gene was associated with IS26. Co-occurrence of numerous resistance genes in a single plasmid possibly contributed to the dissemination of these genes under antibiotics stress. It might explain the presence of clinically crucial resistance genes tet(X) and bla NDM-5 in clinics. This study suggested the applicable use of antibiotics and continued surveillance of tet(X) and bla NDM-5 in clinics are imperative.
Keyphrases
- klebsiella pneumoniae
- escherichia coli
- multidrug resistant
- genome wide
- genome wide identification
- acinetobacter baumannii
- copy number
- public health
- gram negative
- drug resistant
- primary care
- biofilm formation
- transcription factor
- randomized controlled trial
- dna methylation
- bioinformatics analysis
- palliative care
- crispr cas
- physical activity
- pseudomonas aeruginosa
- staphylococcus aureus
- working memory
- genetic diversity
- mass spectrometry